Ventyx Biosciences Inc
NASDAQ:VTYX
Income Statement
Earnings Waterfall
Ventyx Biosciences Inc
Income Statement
Ventyx Biosciences Inc
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||
| Operating Expenses |
(67)
|
(53)
|
(74)
|
(92)
|
(113)
|
(133)
|
(170)
|
(196)
|
(208)
|
(207)
|
(186)
|
(166)
|
(148)
|
(137)
|
(130)
|
(117)
|
|
| Selling, General & Administrative |
(9)
|
(12)
|
(17)
|
(21)
|
(25)
|
(27)
|
(30)
|
(32)
|
(32)
|
(33)
|
(32)
|
(32)
|
(31)
|
(31)
|
(30)
|
(29)
|
|
| Research & Development |
(58)
|
(42)
|
(56)
|
(71)
|
(88)
|
(106)
|
(140)
|
(164)
|
(176)
|
(174)
|
(153)
|
(134)
|
(117)
|
(106)
|
(101)
|
(88)
|
|
| Operating Income |
(67)
N/A
|
(53)
+21%
|
(74)
-38%
|
(92)
-25%
|
(113)
-22%
|
(133)
-18%
|
(170)
-28%
|
(196)
-16%
|
(208)
-6%
|
(207)
+0%
|
(186)
+10%
|
(166)
+10%
|
(148)
+11%
|
(137)
+8%
|
(130)
+5%
|
(117)
+10%
|
|
| Pre-Tax Income | |||||||||||||||||
| Interest Income Expense |
(0)
|
0
|
0
|
0
|
5
|
8
|
12
|
16
|
15
|
15
|
15
|
14
|
13
|
13
|
11
|
10
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(17)
|
0
|
0
|
1
|
0
|
0
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
(84)
N/A
|
(53)
+36%
|
(73)
-38%
|
(91)
-24%
|
(108)
-19%
|
(125)
-15%
|
(158)
-27%
|
(181)
-15%
|
(193)
-6%
|
(193)
+0%
|
(171)
+11%
|
(153)
+11%
|
(135)
+11%
|
(124)
+8%
|
(119)
+4%
|
(107)
+10%
|
|
| Net Income | |||||||||||||||||
| Income from Continuing Operations |
(84)
|
(53)
|
(73)
|
(91)
|
(108)
|
(125)
|
(158)
|
(181)
|
(193)
|
(193)
|
(171)
|
(153)
|
(135)
|
(124)
|
(119)
|
(107)
|
|
| Net Income (Common) |
(85)
N/A
|
(53)
+38%
|
(73)
-38%
|
(91)
-24%
|
(108)
-19%
|
(125)
-15%
|
(158)
-27%
|
(181)
-15%
|
(193)
-6%
|
(193)
+0%
|
(171)
+11%
|
(153)
+11%
|
(135)
+11%
|
(124)
+8%
|
(119)
+4%
|
(107)
+10%
|
|
| EPS (Diluted) |
-1.69
N/A
|
-1.06
+37%
|
-1.45
-37%
|
-1.78
-23%
|
-2.07
-16%
|
-2.16
-4%
|
-2.69
-25%
|
-3.08
-14%
|
-3.3
-7%
|
-3.11
+6%
|
-2.42
+22%
|
-2.15
+11%
|
-1.97
+8%
|
-1.75
+11%
|
-1.68
+4%
|
-1.5
+11%
|
|